A bipartisan group of senators this week introduced a bill that would permanently allow health providers to prescribe buprenorphine, a common medication used to treat opioid addiction, via telehealth.
The measure, known as the Telehealth Response for E-prescribing Addiction Therapy Services Act — TREATS, for short — would permanently extend a temporary, Covid-era policy that allowed patients to receive buprenorphine remotely, without an in-person visit.
While certain law enforcement officials have expressed concern that buprenorphine prescribed remotely could be misused, addiction treatment experts say there’s little evidence to that effect. Amid a public health crisis, they argue, any restrictions on lifesaving medications like buprenorphine would hurt far more than they help.
This article is exclusive to STAT+ subscribers
Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.
Already have an account? Log in
Already have an account? Log in
About the Author Reprints
To submit a correction request, please visit our Contact Us page.
STAT encourages you to share your voice. We welcome your commentary, criticism, and expertise on our subscriber-only platform, STAT+ Connect